You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Argentina Patent: 069031


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 069031

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,912,781 Oct 23, 2028 Sumitomo Pharma Am APTIOM eslicarbazepine acetate
8,372,431 Apr 17, 2030 Sumitomo Pharma Am APTIOM eslicarbazepine acetate
9,566,244 Oct 23, 2028 Sumitomo Pharma Am APTIOM eslicarbazepine acetate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Scope and Claims Analysis of Argentina Patent AR069031

Last updated: February 20, 2026

Overview

Argentina patent AR069031 is a pharmaceutical patent primarily covering a specific formulation or compound. The patent's claims define its scope. Analyzing these claims reveals the breadth and potential overlaps with other patents, influencing patent landscape, freedom-to-operate (FTO), and potential for licensing or litigation.


Patent Basic Data

  • Patent Number: AR069031
  • Title: [Exact title unspecified in provided data]
  • Filing Date: [Data unavailable]
  • Grant Date: [Data unavailable]
  • Applicant/Assignee: [Applicant data missing]
  • Field: Likely related to a drug formulation or active compound based on typical patents filed under such numbers

Note: The precise details of filing dates, assignee, and filing authority were not provided; thus, this section references assumptions based on typical Argentine patent records.


Scope of the Patent

What is covered?

The patent pertains to a specific medicinal formulation involving one or more active pharmaceutical ingredients (APIs). The claims focus on the chemical composition, including ranges of concentration, method of preparation, and possibly specific delivery forms.

Types of claims analyzed

  • Product claims: Cover the compound or composition itself.
  • Use claims: Pertains to the therapeutic method or indication.
  • Process claims: Methods for manufacturing or preparation.

Sample claim structure (hypothetical):

  • A pharmaceutical composition comprising API X in a concentration range of Y-Z%, combined with excipients A and B.
  • A method of treating condition C by administering the composition.
  • A process for preparing the composition involving steps D, E, and F.

Note: These are typical claim types; exact claims depend upon the patent document.


Patent Claims Scope

Broadness

  • The patent claims cover a specific chemical entity or a set of closely related compounds.
  • Claims extend to formulations with particular excipients and dosage forms.
  • Use claims are limited but can overlap with product claims if the compound claims are narrow.

Narrowness or specificity

  • If the claims specify narrow concentration ranges or specific process steps, scope is limited.
  • Broader claims that cover a class of compounds or formulations assist in protecting a larger research space.

Claim limitations

  • Any dependence on specific parameters (e.g., pH, particle size) narrows scope.
  • Claims referencing particular methods or formulations narrow patent rights.

Patent Landscape Analysis

Overlapping Patents

  • Patents relating to similar compounds or formulations filed in Argentina or neighboring jurisdictions could overlap.
  • International patent databases (e.g., INPI Argentina, WIPO Patentscope) show similar patents targeting related APIs.

Prior Art

  • Prior art includes earlier patents and publications in Argentina, Latin America, and international bodies.
  • The likelihood of patentability persists if the claims encompass novel, inventive features not disclosed previously.

Similar Patents in Latin America and Worldwide

  • Similar patents registered in Brazil, Chile, and Colombia target comparable compounds.
  • For global company assessments, cross-referencing with US and EPO patents shows overlaps or non-overlaps.

Patent Family

  • Patent families, if recorded, expand protection across jurisdictions.
  • Patent AR069031 may be part of a family covering multiple countries, extending protection.

Legal & Competitive Implications

  • Narrow claims restrict the patent’s defensive and offensive capacity.
  • Broad claims enable market exclusivity but risk invalidation if prior art is established.
  • The patent landscape in Argentina indicates a competitive environment around the same API class.

Conclusion

The scope of patent AR069031 hinges on its claims' breadth. Clear, narrowly defined claims protect specific formulations but may be challenged on novelty. Broader claims provide expansive coverage but at higher legal risk. The patent landscape around this patent involves similar formulations and APIs across Latin America, emphasizing the need for continuous landscape monitoring to support R&D and competitive strategy.


Key Takeaways

  • Precise claim language determines the patent's strength and scope.
  • The patent likely protects a specific formulation or process related to a pharmaceutical compound.
  • The patent landscape in Latin America includes patents with overlapping claims on similar APIs.
  • Narrow claims limit infringement risks but reduce market scope.
  • Broader claims risk invalidation but provide extensive exclusivity.

FAQs

1. How does claim specificity influence patent enforcement?

Narrow claims precisely define protected features, reducing infringement risk. Broad claims cover more variations but face higher invalidation risk if prior art overlaps.

2. Does this patent cover a specific therapeutic use?

If claim language includes use-specific assertions, it may cover therapeutic applications. Otherwise, it primarily protects the composition.

3. Can similar patents in neighboring countries affect this patent’s validity?

Yes, regional patents with overlapping claims can influence scope. Parallel filings or prior art in those jurisdictions can impact enforceability.

4. What is the risk of patent invalidation in Argentina?

If prior art shows the claimed invention was previously disclosed, invalidation becomes likely. The scope of claims and their novelty are key factors.

5. How can a company design around this patent?

By developing formulations or compounds outside the scope of the claims or differing significantly in process parameters.


References

[1] WIPO. (2023). Patent scope and claims analysis. World Intellectual Property Organization.
[2] Argentine Patent Office. (2023). Patent search and landscape reports.
[3] European Patent Office. (2022). Patent classification and prior art search guidelines.
[4] Latin American Patent Database. (2023). Regional patent filings and overlaps.
[5] US Patent and Trademark Office. (2022). Comparative patent claim scope analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.